©The Author(s) 2025.
World J Gastrointest Endosc. Dec 16, 2025; 17(12): 110432
Published online Dec 16, 2025. doi: 10.4253/wjge.v17.i12.110432
Published online Dec 16, 2025. doi: 10.4253/wjge.v17.i12.110432
Table 3 Correlation of selected clinical parameters with overall survival time
| r value | P value | |
| Age | -0.13 | 0.1004 |
| Time to progression to the next Bismuth stage | 0.56 | 0.0035 |
| Number of ERCP procedures before diagnosis | 0.28 | 0.0003 |
| Number of ERCP procedures after placement of UCSEMS stents | 0.55 | 0.0004 |
| Total number of ERCP procedures | 0.69 | 0.0001 |
| Number of cholangitis episodes in patients with UCSEMS | 0.39 | 0.0467 |
| Number of cholangitis episodes in patients with unilateral plastic | -0.24 | 0.1666 |
| Number of cholangitis episodes in patients with bilateral plastic | 0.19 | 0.1060 |
| Number of cholangitis episodes in patients with mixed approach group | 0.04 | 0.7837 |
| Number of failed ERCP | 0.01 | 0.9236 |
- Citation: Pietrzak J, Pertkiewicz J, Kozieł S, Babski P, Ligocka J, Przybyłkowski A. Endoscopic treatment of malignant hilar biliary obstruction: A retrospective cohort study. World J Gastrointest Endosc 2025; 17(12): 110432
- URL: https://www.wjgnet.com/1948-5190/full/v17/i12/110432.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i12.110432